Johne's Disease Diagnostics Market Size & Growth Forecast 2027–2036, By Segments (End-use, Animal Type, Test Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Johne's Disease Diagnostics Market size stood at USD 776.2 million in 2026 and is predicted to grow at a 5.89% CAGR from 2027 to 2036, surpassing USD 1.38 billion by 2036. The industry revenue for 2027 is calculated at USD 814.7 million.
Get more details on this report
Request Free Sample ReportJohne's Disease Diagnostics Market Intelligence Snapshot
Regional Market Dynamics
- North America captured a 33.92% share in 2026, supported by established veterinary diagnostic infrastructure, routine livestock disease surveillance, and strong collaboration among veterinarians, laboratories, and producers.
- Asia Pacific is projected to grow at a 6.33% CAGR as stronger animal health monitoring, expanding livestock industries, and improved access to veterinary diagnostics increase testing adoption.
Segment Momentum
- Veterinary Hospitals & Clinics accounted for 55.65% of the market in 2026 because they are the primary settings for disease screening, diagnosis, and herd health management.
- Sheep is the fastest-growing animal type as disease surveillance and early diagnostic adoption expand across flock health management programs.
Market Expansion Drivers
- Rising livestock population increasing demand for routine disease diagnostics.
- Government-led Johne’s disease eradication programs strengthening herd testing adoption.
- Expansion of automated point-of-care veterinary diagnostic testing solutions.
Leading Market Participants
- Top players in the johne's disease diagnostics market include IDEXX Laboratories, Inc. (United States), Thermo Fisher Scientific Inc. (United States), Zoetis Inc. (United States), bioMérieux S.A. (France), INDICAL BIOSCIENCE GmbH (Germany), IDvet SAS (France), PBD Biotech Ltd. (United Kingdom), Tetracore, Inc. (United States), VMRD, Inc. (United States), MV Diagnostics Ltd. (United Kingdom).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 776.2 million
- 2027 Estimated Market Size: USD 814.7 million.
- Projected Market Size: USD 1.38 billion by 2036
- Growth Forecast: 5.89% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Veterinary Hospitals & Clinics (End-use) | Cattle (Animal Type) | PCR (Test Type)
- Emerging Opportunity Segment: Veterinary Hospitals & Clinics (End-use) | Sheep (Animal Type) | ELISA (Test Type)
Market Growth Drivers and Industry Trends
Rising livestock population increasing demand for routine disease diagnostics
A growing livestock population is increasing the need for regular herd health monitoring, supporting johne's disease diagnostics market growth through greater demand for routine disease identification. As livestock numbers expand, producers require consistent diagnostic practices to detect disease within herds and support timely management decisions, making diagnostic testing an increasingly relevant component of livestock health programs.
Government-led Johne’s disease eradication programs strengthening herd testing adoption
Government-led johne’s disease eradication initiatives are encouraging wider herd testing and strengthening johne's disease diagnostics market demand by making disease surveillance a more structured part of livestock management. Such programs can promote systematic testing practices across affected herds, increasing the role of diagnostics in identifying disease presence and supporting coordinated eradication efforts.
Expansion of automated point-of-care veterinary diagnostic testing solutions
The expansion of automated point-of-care testing is reshaping johne's disease diagnostics market adoption by enabling veterinary professionals and livestock operators to access diagnostic capabilities closer to the site of care. Faster and more streamlined testing workflows can support timely disease assessment, reduce dependence on lengthy testing processes, and facilitate more efficient herd-level monitoring.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising livestock population increasing demand for routine disease diagnostics | 1.90% | Moderate | Asia Pacific, North America | Medium | Near Term |
| Government-led Johne’s disease eradication programs strengthening herd testing adoption | 2.10% | High | Europe, North America | Medium | Mid Term |
| Expansion of automated point-of-care veterinary diagnostic testing solutions | 1.60% | Moderate | Asia Pacific, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the johne's disease diagnostics market at 33.92% in 2026, supported by established veterinary diagnostic infrastructure, strong livestock health management practices, and growing emphasis on early identification of infectious diseases in dairy and cattle populations. The region benefits from widespread use of laboratory-based testing and established veterinary surveillance systems that facilitate disease monitoring across commercial herds. Greater awareness of the economic impact of chronic livestock infections also encourages producers and veterinary professionals to adopt reliable diagnostic approaches. Ongoing improvements in molecular and immunological testing technologies, together with greater attention to herd biosecurity and animal health management, further reinforce regional demand for johne's disease diagnostics.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing region, driven by expanding dairy and livestock production, rising demand for animal health services, and increasing awareness of infectious disease control. As commercial farming systems become more organized, producers are placing greater emphasis on herd health monitoring, disease prevention, and productivity management. Improvements in veterinary laboratory capabilities and wider access to diagnostic technologies are supporting more systematic detection of johne's disease. Government-led livestock health initiatives, growing investment in agricultural infrastructure, and increasing adoption of modern veterinary practices are also creating favorable conditions for broader diagnostic utilization across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Livestock TestingGermany emphasizes accurate diagnostic testing that supports animal health management and livestock productivity. German veterinary laboratories increasingly adopt standardized diagnostic workflows to improve disease monitoring and farm-level decision-making.
France 🇫🇷
Dairy Health ManagementFrance integrates Johne's disease diagnostics into dairy herd management programs aimed at improving animal health outcomes. French veterinary stakeholders emphasize consistent screening practices and laboratory collaboration to support informed livestock management decisions.
Italy 🇮🇹
Farm Disease PreventionItaly supports the Johne's disease diagnostics market through preventive testing and veterinary monitoring across livestock operations. Italian producers increasingly incorporate routine diagnostic assessments into herd health strategies to reduce operational risks and improve disease control practices.
Japan 🇯🇵
Biosecurity Diagnostic FocusJapan prioritizes reliable Johne's disease diagnostics as part of broader livestock biosecurity initiatives. Veterinary services in Japan increasingly utilize laboratory-based screening and preventive herd health programs to minimize disease transmission risks.
South Korea 🇰🇷
Veterinary Surveillance SupportSouth Korea continues strengthening Johne's disease diagnostics through coordinated veterinary surveillance and livestock health management efforts. Diagnostic laboratories in South Korea focus on efficient testing capabilities that support timely disease identification across cattle farms.
United States 🇺🇸
Herd Health MonitoringThe U.S. Johne's disease diagnostics market focuses on routine herd surveillance and early disease detection across commercial livestock operations. Diagnostic providers in the U.S. continue enhancing laboratory testing capacity and integrated herd management solutions for producers.
Segment Leadership and Growth Trends
Johne's Disease Diagnostics Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Veterinary Hospitals & Clinics (Largest & Fastest-Growing Segment)
Veterinary hospitals & clinics accounted for the largest share of the johne's disease diagnostics market at 55.65% in 2026 and also represent the fastest-growing end-use segment. Their central role in diagnosing and managing infectious diseases in livestock supports consistent demand for diagnostic testing, particularly where early identification is important for herd health management. Veterinary facilities provide access to professional examination, laboratory testing, and disease-monitoring services, making them important points of diagnosis. Increasing attention to livestock health, disease prevention, and productivity preservation is further strengthening the use of johne's disease diagnostic solutions in these settings.
Animal Type Segment Analysis: Cattle (Largest Segment) vs Sheep (Fastest-Growing Segment)
Cattle segment dominated the johne's disease diagnostics market with an 82.65% share in 2026, reflecting the substantial diagnostic need associated with cattle health and herd management. Johne's disease can negatively affect animal condition and farm productivity, increasing the importance of routine disease surveillance and timely identification. Greater emphasis on maintaining herd health, limiting disease transmission, and protecting livestock productivity supports continued reliance on diagnostic testing within cattle populations.
Sheep is projected to be the fastest-growing animal type segment as awareness of disease surveillance expands beyond cattle-focused livestock management. Increasing attention to flock health and preventive veterinary practices is encouraging greater use of diagnostic approaches for identifying and controlling infectious conditions. Improvements in veterinary diagnostic accessibility and growing emphasis on maintaining healthy livestock populations are expected to support wider adoption of johne's disease testing in sheep.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Veterinary Hospitals & Clinics, Others | Veterinary Hospitals & Clinics | Veterinary Hospitals & Clinics |
| Animal Type | Cattle, Goat, Sheep | Cattle | Sheep |
| Test Type | ELISA, PCR, AGID | PCR | ELISA |
Competitive Landscape and Market Positioning
Major players in the johne's disease diagnostics market:
1. IDEXX Laboratories Inc. (United States)
2. Thermo Fisher Scientific Inc. (United States)
3. Zoetis Inc. (United States)
4. bioMérieux S.A. (France)
5. INDICAL BIOSCIENCE GmbH (Germany)
6. IDvet SAS (France)
7. PBD Biotech Ltd. (United Kingdom)
8. Tetracore Inc. (United States)
9. VMRD Inc. (United States)
10. MV Diagnostics Ltd. (United Kingdom)
Rising focus on livestock disease management is strengthening the johne's disease diagnostics market, with ongoing research supporting the development of rapid, accurate diagnostic technologies that improve disease detection and herd health management.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| IDEXX Laboratories Inc. (United States) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Zoetis Inc. (United States) | |||||||
| bioMérieux S.A. (France) | |||||||
| INDICAL BIOSCIENCE GmbH (Germany) | |||||||
| IDvet SAS (France) | |||||||
| PBD Biotech Ltd. (United Kingdom) | |||||||
| Tetracore Inc. (United States) | |||||||
| VMRD Inc. (United States) | |||||||
| MV Diagnostics Ltd. (United Kingdom). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Zoetis | 2025 | Zoetis introduced integrated livestock health management solutions incorporating advanced diagnostic analytics across animal health workflows. The development strengthens its position in end-to-end herd health monitoring, combining diagnostics and data-driven insights to improve disease detection and management across livestock production systems. |
| PBD Biotech | 2025 | PBD Biotech expanded its veterinary diagnostic research programs focused on rapid detection of mycobacterial diseases, including Johne’s disease. The initiative supports advancement of faster diagnostic methodologies and reinforces innovation in early detection tools for livestock disease management and control strategies. |
| IDEXX Laboratories | 2024 | IDEXX expanded PCR-based Johne’s disease testing platforms to support large-scale dairy herd screening. The initiative enhances diagnostic scalability and enables more efficient disease surveillance in livestock populations, reinforcing IDEXX’s position in veterinary molecular diagnostics and supporting broader adoption of PCR-based screening in animal health management systems. |
| INDICAL BIOSCIENCE GmbH | 2024 | INDICAL BIOSCIENCE launched enhanced multiplex PCR assays for livestock disease detection, improving simultaneous identification of multiple pathogens. The development strengthens diagnostic precision and efficiency in veterinary laboratories, supporting broader adoption of multiplex molecular testing in livestock disease control and surveillance programs. |
| Thermo Fisher Scientific, Inc. | 2023 | Thermo Fisher Scientific increased investment in automated veterinary molecular diagnostic systems, supporting expansion of high-throughput testing capabilities. The initiative enhances laboratory efficiency and scalability for livestock disease diagnostics, reinforcing the company’s role in enabling advanced molecular workflows in veterinary healthcare infrastructure. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Johne's Disease Diagnostics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Sample Type | Blood/Serum, Fecal Samples, Milk, Tissue Samples |
| Diagnostic Purpose | Herd Screening, Individual Animal Diagnosis, Surveillance & Monitoring, Pre-Movement/Certification Testing |
| Procurement Model | Direct Purchase by Veterinary Practices, Direct Purchase by Farms & Producers, Government & Regulatory Procurement, Diagnostic Laboratory Procurement |
Johne's Disease Diagnostics Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Livestock Disease Surveillance & Prevention Strategies |
|
| Veterinary Diagnostics Adoption Roadmap |
|
| Precision Livestock Health Opportunities |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the johne's disease diagnostics market?
What is the forecasted size of the johne's disease diagnostics industry?
Why is routine herd screening becoming a strategic priority in the Johne's disease diagnostics market?
How are operational changes improving diagnostic adoption in the Johne's disease diagnostics market?
Why do veterinary hospitals and clinics lead the Johne's disease diagnostics market?
Which animal type is growing the fastest in the Johne's disease diagnostics market?
Why does North America lead the Johne's disease diagnostics market?
What is driving growth in the Johne's disease diagnostics market in Asia Pacific?
Who are the leading players in the johne's disease diagnostics landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization